BD biosciences - clontech:1109645 [16-024303]
Ended Awarded
- Contract number
- HHSN26100017
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,935
Award facts
- Opportunity
-
- N02RC4256357 Solicitation number
- Flow Cytometric Analysis of Benign and Malignant Tumors. Award Notice · Posted Jun 30, 2014
- Contract value 100% obligated
- $16,934.50 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100017?
HHSN26100017 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on February 26, 2016.
How much is contract HHSN26100017 worth?
The government has obligated $16,935 on HHSN26100017.
Is contract HHSN26100017 an order under another contract?
Yes. HHSN26100017 is a delivery order under HHSN261201400013I, an indefinite delivery contract.
Was contract HHSN26100017 competed?
The extent of competition for HHSN26100017 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award